Literature DB >> 189684

Inactivation of lipid-containing viruses by long-chain alcohols.

W Snipes, S Person, G Keller, W Taylor, A Keith.   

Abstract

This report describes the inactivation of lipid-containing viruses by several long-chain alcohols. A striking peak in antiviral activity was found for saturated alcohols having chain lengths from 10 to 14 carbons. Viruses having different membrane structure showed different susceptibilities to alcohols having different chain lengths and structural features. Decanol, dodecanol, and tetradecanol readily inactivated herpes simplex virus and the enveloped bacterial virus phi6. The lipid-containing virus PM2 was susceptible to decanol and dodecanol but comparatively unsusceptible to tetradecanol. The branched-chain alcohol phytol, a naturally occurring component of chlorophyll, was active against phi6 and herpes simplex virus but not against PM2. Polyoma virus and the bacteriophage phi23-1-a, which do not contain lipids, were not susceptible to inactivation by any of the alcohols tested. Experiments were also carried out to determine the effects of these compounds on cells. At 0.5 mM, decanol lysed human embryonic lung cells, erythrocytes, and the bacterial hosts for phi6 and PM2. Dodecanol, tetradecanol, and phytol at this concentration were less damaging to cells. At 0.05 mM, none of the alcohols caused observable cytopathic effects on human embryonic lung cells, although several of the alcohols at this concentration were active against herpes simplex virus. Our findings suggest that dodecanol, tetradecanol, and phytol may warrant further studies as potential antiviral agents, particularly for topical application to virus-infected areas of the skin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 189684      PMCID: PMC351925          DOI: 10.1128/AAC.11.1.98

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Kinetics of cell fusion induced by a syncytia-producing mutant of herpes simplex virus type I.

Authors:  S Person; R W Knowles; G S Read; S C Warner; V C Bond
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

2.  Butylated hydroxytoluene inactivated lipid-containing viruses.

Authors:  W Snipes; S Person; A Keith; J Cupp
Journal:  Science       Date:  1975-04-04       Impact factor: 47.728

3.  Chemotherapy: antiviral agents come of age.

Authors:  T H Maugh
Journal:  Science       Date:  1976-04-09       Impact factor: 47.728

Review 4.  Structure and synthesis of bacteriophage PM2, with particular emphasis on the viral lipid bilayer.

Authors:  R M Franklin
Journal:  Curr Top Microbiol Immunol       Date:  1974       Impact factor: 4.291

5.  Temperature sensitivity of the assembly process of the enveloped bacteriophage phi6.

Authors:  J A Sands; J Cupp; A Keith; W Snipes
Journal:  Biochim Biophys Acta       Date:  1974-12-10

6.  Calcium requirement for assemby of the lipid-containing bacteriophage PM2.

Authors:  W Snipes; J Cupp; J A Sands; A Keith; A Davis
Journal:  Biochim Biophys Acta       Date:  1974-03-29

7.  Lipid and protein arrangement in bacteriophage PM2.

Authors:  S C Harrison; D L Caspar; R D Camerini-Otero; R M Franklin
Journal:  Nat New Biol       Date:  1971-02-17

8.  Effects of 2-deoxyglucose, glucosamine, and mannose on cell fusion and the glycoproteins of herpes simplex virus.

Authors:  R W Knowles; S Person
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

9.  Inactivation of the lipid-containing bacteriophage PM2 by butylate hydroxytoluene.

Authors:  J Cupp; P Wanda; A Keith; W Snipes
Journal:  Antimicrob Agents Chemother       Date:  1975-12       Impact factor: 5.191

10.  Inactivation of the enveloped bacteriophage phi6 by butylated hydroxytoluene and butylated hydroxyanisole.

Authors:  P Wanda; J Cupp; W Snipes; A Deith; T Rucinsky; L Polish; J Sands
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

View more
  11 in total

1.  Enveloped virus inactivation by fatty acid derivatives.

Authors:  J A Sands; L D Auperin; A Reinhardt
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

2.  Antiviral activity of 1-docosanol, an inhibitor of lipid-enveloped viruses including herpes simplex.

Authors:  D H Katz; J F Marcelletti; M H Khalil; L E Pope; L R Katz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

Review 3.  How were new medicines discovered?

Authors:  David C Swinney; Jason Anthony
Journal:  Nat Rev Drug Discov       Date:  2011-06-24       Impact factor: 84.694

4.  Extreme sensitivity of enveloped viruses, including herpes simplex, to long-chain unsaturated monoglycerides and alcohols.

Authors:  J Sands; D Auperin; W Snipes
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

5.  Inactivation and inhibition of replication of the enveloped bacteriophage phi6 by fatty acids.

Authors:  J A Sands
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

6.  Virucidal activity of retinal.

Authors:  A Reinhardt; J A Sands; W Snipes
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

7.  Mechanism of virucidal activity of retinoids: protein removal from bacteriophage phi 6 envelope.

Authors:  A Reinhardt; D Auperin; J Sands
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

8.  Inhibitory effect of fatty acids on the entry of the lipid-containing bacteriophage PR4 into Escherichia coli.

Authors:  A Reinhardt; S Cadden; J A Sands
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

9.  Inactivation of mycoplasmas by long-chain alcohols.

Authors:  R D Fletcher; J R Gilbertson; A C Albers; J D White
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

10.  Characteristics of a new bacteriophage, Psp231a, infecting Pseudomonas phaseolicola HB10Y.

Authors:  W D Taylor; N DeLuca; K Vollherbst; T Doman; T d'Amato; W Snipes
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.